查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年微流体市场预测：按产品、材料、技术、最终用户和地区分類的全球分析
市场调查报告书
商品编码
1383501

2030 年微流体市场预测：按产品、材料、技术、最终用户和地区分類的全球分析

Microfluidics Market Forecasts to 2030 - Global Analysis By Product (Microfluidics-Based Device, Microfluidics Components and Other Products), Material (Polymer, Metal, Ceramics, Silicon and Glass), Technology, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2023年全球微流控市场规模将达223亿美元，预计2030年将达到593亿美元，预测期内年复合成长率为15%。

微流控是一种用于研究流体性质和性质的技术方法。微流体是一种用于研究流体性质和特性的技术方法，其应用包括使用一套工具来操纵和控制小体积流体中的化学和生物过程。它也用于製造包含许多用于流体通过和容纳的腔室和隧道的超小型设备。

根据 Globocan 2020 的数据，2020 年全球新增癌症患者人数为 19,282,789 人，预计 2040 年将增加至 28,887,940 人。

技术进步

大规模微流控整合和软光刻极大地扩展了在医学和生物科学研究中的应用。这些技术进步加速了研究和开发，使研究人员能够在更复杂和精密的微流控晶片上进行实验。此外，微流体组件正迅速成为化学合成、生物感测、生物驱动和医学等越来越多领域的基本技术。这些因素正在推动市场需求。

高成本

开发和製造流程的高成本极大地阻碍了微流体装置的广泛普及。常用的技术包括光刻、软光刻和微加工，但这些设备的安装和维护成本昂贵。此外，微流体中使用的材料（例如玻璃和聚合物）可能比其他行业中使用的传统材料更昂贵。这些因素阻碍了微流体市场的成长。

即时诊断的需求

由于即时诊断需求激增，预计微流体市场在预测期内将实现盈利成长。与其他传统方法相比，即时诊断可以快速且快速地检测疾病。它还可以更好地监测、诊断和治疗患者，并促进医疗专业人员更快地做出决策。

漫长而复杂的法规过程

医疗设备製造商必须遵守严格的法规政策，以确保其器材的安全性和有效性。医疗设备核准流程变得越来越复杂和漫长。一些整合微流体医疗设备核准需要时间才能获得法规的核准，否则您的投资可能会被浪费。这些因素阻碍了微流控市场的扩张。

COVID-19 的影响

COVID-19 大流行对微流体市场产生了有益的影响。高需求的诊断包括 COVID-19 测试、快速诊断测试以及使用微流体技术进行药物研发的体外诊断。一些行业相关人员专注于引入基于微流体技术的快速抗原测试来诊断 COVID-19。为了对抗这场流行病，法规还承诺支持批准微流体测试。随着体外诊断 (IVD) 设备、护理点测试和快速诊断测试的增加，对微流控试剂盒的需求预计也会增加，以确保患者样本结果的准确性和精密度。不过，预计未来市场将稳定復苏并相对成长。

体外诊断领域预计将在预测期内成为最大的领域。

许多诊断、製药和生物技术公司以及法医学应用都使用采用微流体技术的 IVD，例如 PCR 系统、分析仪、PoC 诊断和电泳系统。这些设备具有多种优势，包括便携性、提高测试频率、减少试剂和样品消费量以及准确快速的分析。此外，推动基于微流体的概念验证(PoC) 技术的使用增加的其他重要因素包括廉价消耗品的可用性，以及提供紧凑、整合系统和更快测试结果的 PoC 设备，并且成本可以降低显着减少。

预计微流控设备产业在预测期间内年复合成长率最高

预计基于微流体的设备领域将在预测期内出现良好的成长。微流体装置可以显着增强奈米颗粒和奈米复合材料的合成。原因是微反应器中有效的传热和传质、空间限制、参数调整的便利性以及原位製程监控。许多具有可调尺寸、尺寸分布和形态的奈米颗粒，包括混合、无机奈米颗粒和型态，已使用微流体装置成功合成。此外，自动化微型机器人注射、药物研发和分析以及单细胞捕获都是微流体装置的医学应用。

比最大的地区

由于创新技术的引入、成熟的市场参与者的存在、改进样本最佳化的选定研究数量的增加以及对 POC 诊断的巨大需求，北美在预测期内占据了最大的市场占有率。此外，研究机构继续在创新微流体设备的开发中发挥主导作用，并有望在可预见的未来保持其在该地区的主导地位。

复合年复合成长率最高的地区：

由于先进的研究基础设施、经济成长和劳动力供应，预计亚太地区将在预测期内实现有益成长。此外，亚太地区拥有许多支持微流体技术发展的才华横溢的科学家、工程师和研究人员。这些专家正在积极致力于开发生物技术、製药、医疗保健和环境监测等领域的尖端微流体应用。然而，该地区的主要企业正在提出独特的、具有吸引力的、重点具有成本效益的解决方案，并且有可能在未来年度增加市场占有率。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球微流控市场：分产品

  • 基于微流体的设备
  • 微流体元件
    • 流量感测器和压力感测器
    • 微流控晶片
    • 微型帮浦
    • 流量和压力控制器
    • 微型针
    • 微流阀
  • 其他产品

第6章全球微流控市场：依材料分类

  • 聚合物
    • 非聚氯乙烯
    • PVC
  • 金属
  • 陶瓷
  • 硅
  • 玻璃

第7章全球微流控市场：依技术分类

  • 非医疗用途
  • 医疗用途

第8章全球微流控市场：依应用分类

  • 製药与生命科学研究与製造
    • 实验室分析
      • 基于细胞的检测
      • 蛋白质体分析
      • 毛细管电泳
      • 基因组分析
    • 微分配
    • 微反应
  • 体外诊断
    • 即时检测
    • 临床诊断
    • 兽医诊断
  • 疗法
    • 穿戴式装置
    • 药物输送

第9章全球微流体市场：依最终用户分类

  • 学术研究所
  • 医院/诊断中心
  • 製药和生物技术公司

第10章全球微流控市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第11章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第12章公司简介

  • Thermofisher
  • Biomerieux
  • Quidel Corporation
  • Illumina Inc
  • Fluidigm Corporation
  • Abbott Laboratories
  • Smc Corporation
  • Perkinelmer
  • Idex Corporation
  • Hologic
  • Parker-Hannifin Corporation
  • Becton, Dickinson, and Company
  • Agilent
  • Bio-RAD
  • Hoffmann La-Roche
  • Danaher Corporation
  • Fortive Corporation
  • Aignep SPA
  • Dolomite Microfluidics
  • Elveflow
Product Code: SMRC24349

According to Stratistics MRC, the Global Microfluidics Market is accounted for $22.3 billion in 2023 and is expected to reach $59.3 billion by 2030 growing at a CAGR of 15% during the forecast period. Microfluidics is a technological method used to investigate the nature and characteristics of fluids. Its application involves the manipulation and control of small volumes of fluids' chemical and biological processes through the use of a set of tools. It is also employed in the creation of microminiaturized apparatuses that contain a large number of chambers and tunnels that allow fluids to pass through or be contained.

According to Globocan 2020, there were 19,282,789 new cancer cases worldwide in 2020, with a projected increase to 28,887,940 cases by 2040.

Market Dynamics:

Driver:

Technological advancements

Large-scale microfluidics integration and soft lithography have greatly expanded their applications in medical and biological science research. These technological advancements have accelerated development efforts and allowed researchers to carry out experiments on microfluidics chips with greater complexity and sophistication. Additionally, microfluidics components are quickly becoming an indispensable technology in a growing number of fields, such as chemical synthesis, bio sensing, bio actuation, and medicine. These factors are propelling market demand.

Restraint:

High cost

Widespread adoption of microfluidics devices is severely hampered by the high cost of the development and manufacturing processes. Frequently employed methods include photolithography, soft lithography, and micro-machining, which can be expensive to set up and maintain in terms of equipment. Furthermore, the materials used in microfluidics, like glass or polymers, might be more expensive than conventional materials used in other industries. These factors are hampering the growth of the microfluidics market.

Opportunity:

Demand for point-of-care diagnostics

The microfluidics market is anticipated to exhibit profitable growth potential over the forecast period due to the surge in demand for point-of-care diagnostics. Point-of-care diagnostics offer rapid and quick detection of diseases as compared to other conventional methods. Moreover, better patient monitoring, diagnosis, and treatment results from this and it also facilitate prompt medical decision-making by medical professionals.

Threat:

Time-consuming and complex regulatory process

Manufacturers of medical devices are required to comply with stringent regulatory policies to ensure the safety and efficacy of the devices. The approval process for medical devices has grown increasingly complicated and drawn out. Certain integrated microfluidics medical devices may take a while to receive regulatory approval, and if this is denied, there is a chance that investment will be wasted. These elements are hindering the expansion of the microfluidics market.

COVID-19 Impact

The COVID-19 pandemic had a beneficial effect on the microfluidics market. In-demand diagnostics included COVID-19 testing, rapid diagnostic tests, and IVDs that use microfluidic technology for drug discovery. Several industry participants were focusing on introducing rapid antigen testing based on microfluidics technology to diagnose COVID-19. In an attempt to combat the pandemic, regulatory bodies also promised to support the approval of microfluidics testing. In order to ensure the accuracy and precision of patient sample results, microfluidics kits were predicted to become more in demand as the number of IVD devices, point-of-care testing, and rapid diagnostic tests increased. However, the market is expected to show a steady recovery and relative increase in the future.

The in vitro diagnostics segment is expected to be the largest during the forecast period

The in vitro diagnostics segment is estimated to hold the largest share A growing number of diagnostic, pharmaceutical, and biotechnology companies, as well as forensic applications, are using IVD embedded with microfluidics technologies, such as PCR systems, analyzers, PoC diagnostics, and electrophoretic systems. Multiple advantages are offered by these devices, including portability, increased testing frequency, reduced reagent and sample consumption, and precise and speedy analysis. Moreover, other important factors driving the increased use of microfluidics-based proof-of-concept (PoC) technologies include the availability of inexpensive consumables and the ability of PoC devices to obtain faster test results with compact integrated systems and significantly lower costs.

The microfluidics-based device segment is expected to have the highest CAGR during the forecast period

The microfluidics-based device segment is anticipated to have lucrative growth during the forecast period. The synthesis of nanoparticles and nanocomposites could be greatly enhanced by microfluidics devices because of their effective heat and mass transfers, spatial limitations, ease of parameter adjustment, and in situ process monitoring in micro reactors. Many nanoparticles with tunable sizes, size distributions, and morphologies, including hybrid, inorganic, and organic ones, have been successfully synthesized using microfluidics devices. Moreover, automated micro-robotic injection, drug discovery and analysis, and single-cell trapping are among the biomedical uses of microfluidics devices.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to the introduction of innovative technologies, the presence of well-established market players, the rise in the number of studies chosen to improve sample optimization, and the substantial demand for POC diagnostics. Furthermore, it is anticipated that research institutes will continue to play a leading role in the development of innovative microfluidics devices, maintaining their dominance in the region for the foreseeable future.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period, owing to the advanced infrastructure for research, the growing economy, and the accessibility of labor. Furthermore, a sizable pool of highly qualified scientists, engineers, and researchers who support the development of microfluidics technologies reside in the Asia Pacific region. These experts are actively engaged in creating cutting-edge microfluidics applications in fields like biotechnology, pharmaceuticals, healthcare, and environmental monitoring. However, prominent players in the region are putting forth creative and intriguing performance- and, more importantly, cost-effective solutions, which may enable them to increase their market share in the years to come.

Key players in the market

Some of the key players in the Microfluidics Market include: Thermofisher, Biomerieux, Quidel Corporation, Illumina Inc, Fluidigm Corporation, Abbott Laboratories, Smc Corporation, Perkinelmer, Idex Corporation, Hologic, Parker-Hannifin Corporation, Becton, Dickinson, and Company, Agilent, Bio-RAD, Hoffmann La-Roche, Danaher Corporation, Fortive Corporation, Aignep S.P.A, Dolomite Microfluidics and Elveflow.

Key Developments:

In July 2021, Abbott launched the Panbio COVID-19 Antigen Self-Test in India for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms.

In June 2021, Danaher's Life science segment acquired Precision Nanosystems (PNI) to complement the former vaccines and therapeutics development business.

In February 2021, Thermo fisher acquired the point-of-care molecular diagnostic company Mesa Biotech, Inc. This is expected to raise Thermo fisher's revenue by approximately USD 200 million.

Products Covered:

  • Microfluidics-Based Device
  • Microfluidics Components
  • Other Products

Materials Covered:

  • Polymer
  • Metal
  • Ceramics
  • Silicon
  • Glass

Technologies Covered:

  • Pharmaceutical & Life Science Research and Manufacturing
  • In Vitro Diagnostics
  • Therapeutics

End Users Covered:

  • Academic and Research Institutes
  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotechnology Companies

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Microfluidics Market, By Product

  • 5.1 Introduction
  • 5.2 Microfluidics-Based Device
  • 5.3 Microfluidic Components
    • 5.3.1 Flow and Pressure Sensors
    • 5.3.2 Microfluidic Chip
    • 5.3.3 Micropumps
    • 5.3.4 Flow and Pressure Controllers
    • 5.3.5 Microneedles
    • 5.3.6 Microfluidic Valves
  • 5.4 Other Products

6 Global Microfluidics Market, By Material

  • 6.1 Introduction
  • 6.2 Polymer
    • 6.2.1 Non-polyvinyl Chloride
    • 6.2.2 Polyvinyl Chloride
  • 6.3 Metal
  • 6.4 Ceramics
  • 6.5 Silicon
  • 6.6 Glass

7 Global Microfluidics Market, By Technology

  • 7.1 Introduction
  • 7.2 Non-Medical
  • 7.3 Medical

8 Global Microfluidics Market, By Application

  • 8.1 Introduction
  • 8.2 Pharmaceutical & Life Science Research and Manufacturing
    • 8.2.1 Lab Analytics
      • 8.2.1.1 Cell-Based Assays
      • 8.2.1.2 Proteomic Analysis
      • 8.2.1.3 Capillary Electrophoresis
      • 8.2.1.4 Genomic Analysis
    • 8.2.2 Microdispensing
    • 8.2.3 Microreaction
  • 8.3 In Vitro Diagnostics
    • 8.3.1 Point Of Care Testing
    • 8.3.2 Clinical Diagnostics
    • 8.3.3 Veterinary Diagnostics
  • 8.4 Therapeutics
    • 8.4.1 Wearable Devices
    • 8.4.2 Drug Delivery

9 Global Microfluidics Market, By End User

  • 9.1 Introduction
  • 9.2 Academic and Research Institutes
  • 9.3 Hospitals and Diagnostic Centers
  • 9.4 Pharmaceutical and Biotechnology Companies

10 Global Microfluidics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Thermofisher
  • 12.2 Biomerieux
  • 12.3 Quidel Corporation
  • 12.4 Illumina Inc
  • 12.5 Fluidigm Corporation
  • 12.6 Abbott Laboratories
  • 12.7 Smc Corporation
  • 12.8 Perkinelmer
  • 12.9 Idex Corporation
  • 12.10 Hologic
  • 12.11 Parker-Hannifin Corporation
  • 12.12 Becton, Dickinson, and Company
  • 12.13 Agilent
  • 12.14 Bio-RAD
  • 12.15 Hoffmann La-Roche
  • 12.16 Danaher Corporation
  • 12.17 Fortive Corporation
  • 12.18 Aignep S.P.A
  • 12.19 Dolomite Microfluidics
  • 12.20 Elveflow

List of Tables

  • Table 1 Global Microfluidics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Microfluidics Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Microfluidics Market Outlook, By Microfluidics-Based Device (2021-2030) ($MN)
  • Table 4 Global Microfluidics Market Outlook, By Microfluidic Components (2021-2030) ($MN)
  • Table 5 Global Microfluidics Market Outlook, By Flow and Pressure Sensors (2021-2030) ($MN)
  • Table 6 Global Microfluidics Market Outlook, By Microfluidic Chip (2021-2030) ($MN)
  • Table 7 Global Microfluidics Market Outlook, By Micropumps (2021-2030) ($MN)
  • Table 8 Global Microfluidics Market Outlook, By Flow and Pressure Controllers (2021-2030) ($MN)
  • Table 9 Global Microfluidics Market Outlook, By Microneedles (2021-2030) ($MN)
  • Table 10 Global Microfluidics Market Outlook, By Microfluidic Valves (2021-2030) ($MN)
  • Table 11 Global Microfluidics Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 12 Global Microfluidics Market Outlook, By Material (2021-2030) ($MN)
  • Table 13 Global Microfluidics Market Outlook, By Polymer (2021-2030) ($MN)
  • Table 14 Global Microfluidics Market Outlook, By Non-polyvinyl Chloride (2021-2030) ($MN)
  • Table 15 Global Microfluidics Market Outlook, By Polyvinyl Chloride (2021-2030) ($MN)
  • Table 16 Global Microfluidics Market Outlook, By Metal (2021-2030) ($MN)
  • Table 17 Global Microfluidics Market Outlook, By Ceramics (2021-2030) ($MN)
  • Table 18 Global Microfluidics Market Outlook, By Silicon (2021-2030) ($MN)
  • Table 19 Global Microfluidics Market Outlook, By Glass (2021-2030) ($MN)
  • Table 20 Global Microfluidics Market Outlook, By Technology (2021-2030) ($MN)
  • Table 21 Global Microfluidics Market Outlook, By Non-Medical (2021-2030) ($MN)
  • Table 22 Global Microfluidics Market Outlook, By Medical (2021-2030) ($MN)
  • Table 23 Global Microfluidics Market Outlook, By Application (2021-2030) ($MN)
  • Table 24 Global Microfluidics Market Outlook, By Pharmaceutical & Life Science Research and Manufacturing (2021-2030) ($MN)
  • Table 25 Global Microfluidics Market Outlook, By Lab Analytics (2021-2030) ($MN)
  • Table 26 Global Microfluidics Market Outlook, By Microdispensing (2021-2030) ($MN)
  • Table 27 Global Microfluidics Market Outlook, By Microreaction (2021-2030) ($MN)
  • Table 28 Global Microfluidics Market Outlook, By In Vitro Diagnostics (2021-2030) ($MN)
  • Table 29 Global Microfluidics Market Outlook, By Point Of Care Testing (2021-2030) ($MN)
  • Table 30 Global Microfluidics Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
  • Table 31 Global Microfluidics Market Outlook, By Veterinary Diagnostics (2021-2030) ($MN)
  • Table 32 Global Microfluidics Market Outlook, By Therapeutics (2021-2030) ($MN)
  • Table 33 Global Microfluidics Market Outlook, By Wearable Devices (2021-2030) ($MN)
  • Table 34 Global Microfluidics Market Outlook, By Drug Delivery (2021-2030) ($MN)
  • Table 35 Global Microfluidics Market Outlook, By End User (2021-2030) ($MN)
  • Table 36 Global Microfluidics Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 37 Global Microfluidics Market Outlook, By Hospitals and Diagnostic Centers (2021-2030) ($MN)
  • Table 38 Global Microfluidics Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.